- Home
- VOXR vs SCPH Comparison
VOXR vs SCPH Comparison
Compare VOXR & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOXR
- SCPH
- Stock Information
- Founded
- VOXR 2014
- SCPH 2013
- Country
- VOXR United States
- SCPH United States
- Employees
- VOXR N/A
- SCPH N/A
- Industry
- VOXR Precious Metals
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- VOXR Basic Materials
- SCPH Health Care
- Exchange
- VOXR Nasdaq
- SCPH Nasdaq
- Market Cap
- VOXR 145.9M
- SCPH 173.6M
- IPO Year
- VOXR N/A
- SCPH 2017
- Fundamental
- Price
- VOXR $3.26
- SCPH $2.51
- Analyst Decision
- VOXR
- SCPH Strong Buy
- Analyst Count
- VOXR 0
- SCPH 3
- Target Price
- VOXR N/A
- SCPH $14.00
- AVG Volume (30 Days)
- VOXR 254.3K
- SCPH 474.7K
- Earning Date
- VOXR 05-07-2025
- SCPH 05-13-2025
- Dividend Yield
- VOXR 1.53%
- SCPH N/A
- EPS Growth
- VOXR N/A
- SCPH N/A
- EPS
- VOXR N/A
- SCPH N/A
- Revenue
- VOXR $11,047,763.00
- SCPH $36,332,000.00
- Revenue This Year
- VOXR $16.51
- SCPH $114.00
- Revenue Next Year
- VOXR $4.60
- SCPH $77.45
- P/E Ratio
- VOXR N/A
- SCPH N/A
- Revenue Growth
- VOXR N/A
- SCPH 167.28
- 52 Week Low
- VOXR $1.93
- SCPH $1.94
- 52 Week High
- VOXR $3.57
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- VOXR 58.93
- SCPH 45.37
- Support Level
- VOXR $3.30
- SCPH $2.50
- Resistance Level
- VOXR $3.46
- SCPH $2.76
- Average True Range (ATR)
- VOXR 0.17
- SCPH 0.23
- MACD
- VOXR 0.02
- SCPH 0.04
- Stochastic Oscillator
- VOXR 69.31
- SCPH 69.51
About VOXR Vox Royalty Corp.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.